COMERICA BANK - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 335 filers reported holding IMMUNOGEN INC in Q4 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.7%.

Quarter-by-quarter ownership
COMERICA BANK ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q4 2023$752,487
+86.8%
25,3790.0%0.00%
+50.0%
Q3 2023$402,765
+719123.2%
25,379
+103.0%
0.00%
Q4 2022$56
-99.9%
12,500
-4.8%
0.00%
-100.0%
Q3 2022$79,000
+17.9%
13,1370.0%0.00%0.0%
Q2 2022$67,000
-1.5%
13,137
-0.5%
0.00%
Q1 2022$68,000
-5.6%
13,2030.0%0.00%
-100.0%
Q4 2021$72,000
-7.7%
13,203
+0.4%
0.00%
Q3 2021$78,000
-17.0%
13,144
-29.9%
0.00%
-100.0%
Q2 2021$94,000
-35.6%
18,7470.0%0.00%0.0%
Q1 2021$146,000
+2.1%
18,747
-3.7%
0.00%0.0%
Q4 2020$143,000
-11.7%
19,472
-34.5%
0.00%0.0%
Q3 2020$162,000
+90.6%
29,721
+56.8%
0.00%0.0%
Q2 2020$85,000
+9.0%
18,950
-1.0%
0.00%0.0%
Q1 2020$78,000
-7.1%
19,134
+11.2%
0.00%0.0%
Q4 2019$84,000
+82.6%
17,203
-1.1%
0.00%
Q3 2019$46,000
+17.9%
17,389
-0.2%
0.00%
Q2 2019$39,000
-17.0%
17,425
+1.1%
0.00%
Q1 2019$47,000
-43.4%
17,2320.0%0.00%
-100.0%
Q4 2018$83,000
-22.4%
17,232
+0.3%
0.00%0.0%
Q3 2018$107,000
-44.3%
17,189
-10.3%
0.00%0.0%
Q2 2018$192,000
+2.1%
19,168
+4.3%
0.00%0.0%
Q1 2018$188,000
+37.2%
18,369
+12.2%
0.00%0.0%
Q4 2017$137,000
+50.5%
16,369
+3.4%
0.00%0.0%
Q3 2017$91,000
-9.0%
15,8240.0%0.00%0.0%
Q2 2017$100,000
+35.1%
15,824
-7.3%
0.00%0.0%
Q1 2017$74,000
+80.5%
17,0670.0%0.00%
Q4 2016$41,000
+13.9%
17,067
+20.7%
0.00%
Q3 2016$36,000
-7.7%
14,140
+9.6%
0.00%
Q2 2016$39,000
-67.2%
12,8970.0%0.00%
-100.0%
Q1 2016$119,000
-15.6%
12,897
-1.5%
0.00%0.0%
Q4 2015$141,000
+8.5%
13,099
-3.0%
0.00%0.0%
Q3 2015$130,000
-67.2%
13,511
-50.9%
0.00%
-50.0%
Q2 2015$396,000
+227.3%
27,522
+103.3%
0.00%
+100.0%
Q1 2015$121,000
-27.1%
13,537
-50.3%
0.00%0.0%
Q4 2014$166,000
+17.7%
27,242
+103.7%
0.00%0.0%
Q3 2014$141,000
-14.5%
13,374
-4.1%
0.00%0.0%
Q2 2014$165,000
-46.9%
13,944
-32.9%
0.00%
-50.0%
Q1 2014$311,000
+3.0%
20,792
+1.0%
0.00%0.0%
Q4 2013$302,000
-71.2%
20,580
-66.6%
0.00%
-71.4%
Q3 2013$1,049,000
+6.6%
61,634
+4.0%
0.01%
-12.5%
Q2 2013$984,00059,2720.01%
Other shareholders
IMMUNOGEN INC shareholders Q4 2023
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders